Search Results
Mar 02, 2026, 17:52 ET In HelloNation, Real Estate Expert Ryan Lerwill of Rexburg, ID, Explains Down Payment Myths
Myth vs. Fact: You Need 20% Down to Buy a Home features insights from Ryan Lerwill, Real Estate Expert of Rexburg, ID, in HelloNation.About
More news about: HelloNation
Mar 02, 2026, 16:10 ET Dave Reports Fourth Quarter & Full Year 2025 Financial Results
$163.7% Change vs. prior year period38 %
More news about: Dave Inc.
Mar 02, 2026, 12:48 ET DBX6: Garcia vs. Perez for Interim Title in Miami April 10, 2026 and Jon Jones Meet and Greet
multimedia:https://www.prnewswire.com/news-releases/dbx6-garcia-vs-perez-for-interim-title-in-miami-april-10-2026-and-jon-jones-meet-and-greet-302701346.htmlSOURCE
More news about: Dirty Boxing Championship
Mar 02, 2026, 11:48 ET In HelloNation, Expert Financial Advisor Scott Ferguson Explains Saving vs Investing
HelloNation article, Scott Ferguson of Financial Concepts in Columbus, Mississippi, outlines how understanding saving vs investing can help people make better financial decisions and build long-term stability.
More news about: HelloNation
Mar 02, 2026, 11:00 ET GENESIS CONTINUES SUPPORT OF FIRST TEE WITH $100,000 DONATION
representatives from across the First Tee organization—including coaches, students, staff, board members, and trustees—were hosted during the New York Golf Club vs. The Bay Golf Club match.
More news about: Genesis Motor America
Mar 02, 2026, 09:52 ET Levi & Korsinsky Issues Summary Notice of Class Action Settlement
PLAINTIFFS, VS. MARK LINDON, MICHAEL DREYER, ANOOSHEH BOSTANI,
More news about: Levi & Korsinsky, LLP
Mar 02, 2026, 09:04 ET BISSELL® Tackles Ever-Present Pet Messes Automatically with New FlexClean™ FurForce™: The 2‑in‑1 Robot That Vacuums and Mops Anytime, Anywhere
[email protected] vs. Shark Matrix RV2610WA ASTM F588 at motor inlet.2 vs. Shark Matrix RV2610WA based on hair weight in tank.3 vs. Shark Matrix RV2610WA ASTM F588 at motor inlet.4 vs. Shark Matrix RV2610WA based
More news about: BISSELL Homecare, Inc.
Mar 02, 2026, 09:02 ET BISSELL® Takes Old-School Scrubbing Out of Cleaning with New CrossWave® HydroScrub™ Wet Dry Vacuum Cleaner
1 Vs. PowerMop Mode2 Vs. PowerMop Mode3 Vs. CrossWave®
More news about: BISSELL Homecare, Inc.
Mar 02, 2026, 09:00 ET Superior Efficacy and Long-acting: LongBio Announces Positive Topline Results from Phase II CSU Trial of Next-Generation Anti-IgE Therapy, LP-003 in Head-to-Head Comparison with Xolair®
were 44.4%, 66.7%, 57.5%, 43.6% and 10.8% in the LP-003 100 mg Q8W, 200 mg Q8W, 200 mg Q4W, Omalizumab, and placebo groups, respectively (200 mg Q8W vs. Omalizumab, p=0.0405).For the second key efficacy endpoint, LS mean changes from baseline in UAS7 at Week 12 were -23.15,
More news about: LongBio
Mar 02, 2026, 09:00 ET EOS DOUBLES CASHMERE BODY WASH OFFERING IN RESPONSE TO FAN DEMAND
www.evolutionofsmooth.com.* Source: L52W Nielsen chg in $ vs YA across WMT, TGT, Grocery, Drug. Excl Men's BW
More news about: eos Products
Mar 02, 2026, 09:00 ET Supermicro breidt de ondersteuning uit voor AI-RAN- en Sovereign AI-oplossingen om een hoogwaardige, efficiënte en schaalbare AI-infrastructuur te leveren
volgende generatie, van cloud tot edge, mogelijk wordt voor onze wereldwijde klanten. Onze producten worden in-house ontworpen en geproduceerd (in de VS, Taiwan en Nederland), waarbij maximaal gebruik wordt gemaakt van wereldwijde operaties voor schaal en efficiëntie, en geoptimaliseerd om de TCO te verbeteren
More news about: Super Micro Computer, Inc.
Mar 02, 2026, 08:30 ET AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease
induction achieved the co-primary endpoints of Crohn's Disease Activity Index (CDAI) clinical remissiona (55% vs. 30%; p<0.0001) and endoscopic responseb (44% vs. 14%; p<0.0001) at week 12 compared to placebo.1 Among patients with clinical responsec after
More news about: AbbVie
Mar 02, 2026, 08:03 ET Decentralized Clinical Trial Validates Novel "Fasting Mimetic" Formulation for Cardiometabolic Health
Significant reductions in Total Cholesterol, LDL, Oxidized LDL, and Fasting Glucose vs. placebo.91% of participants in the active group reported improved mealtime appetite regulation (vs. 47% in placebo).Confirmed safety and tolerability for daily use.Full
More news about: People Science, Inc.
Mar 02, 2026, 08:02 ET Mimio Health Announces Breakthrough Clinical Trial Of Its Fasting Mimetic, Demonstrating Fasting-Like Benefits Without Dietary Changes
distraction from cravings, and mealtime appetite, and improved satiety vs the placebo groupThe formulation was confirmed to be well tolerated for daily use and significantly reduced reports of bloating and digestive discomfort vs the placebo group.Full Publication: Nature Scientific
More news about: Mimio Health, Inc.
Mar 02, 2026, 08:01 ET Hairitage by Mindy Redefines "Clean" Haircare with Next Gen Shampoos & Conditioners - Exclusively at Walmart This March
coastal woods. Recommended for Straight, Wavy, Curly, or Coily Hair.*When using Hairitage shampoo and conditioner pairs as a system vs. untreated hair"We approached Next Gen Shampoos & Conditioners as both a formula evolution and a brand moment," says Nadia Khan, SVP
More news about: Hairitage
Mar 02, 2026, 07:00 ET Astrana Health, Inc. Reports Fourth Quarter and Year End 2025 Results
% change vs. prior year
More news about: Astrana Health, Inc.
Mar 02, 2026, 01:01 ET New research links testosterone therapy with serious health risks after total knee replacement surgery
of pulmonary embolism (PE) (1.6% vs. 1.2%, P = 0.041), pneumonia (3.3% vs. 1.9%, P <0.001), acute kidney injury (AKI) (4.2% vs. 2.9%, P < 0.001), and sepsis (1.9% vs. 1.1%, P < 0.001).At one year, TRT was associated with increased rates of PE (2.6% vs. 2.0%, P < 0.015), deep vein thrombosis
More news about: American Academy of Orthopaedic Surgeons
Mar 02, 2026, 01:01 ET Research in college and NFL athletes links early sports specialization to higher injury rates
hip/groin pain (62.7% vs. 53.3%, p = 0.0035) and more likely to quit their primary sport entirely due to injury (68.0% vs. 55.4%, p<0.0001).Female athletes had a higher rate of hip/groin pain than males (58.6% vs. 49.8%), as well as higher rates of non-surgical treatment (57.5% vs. 44.7%) and surgical
More news about: American Academy of Orthopaedic Surgeons
Mar 02, 2026, 01:01 ET Robotic-assisted arthroplasty shows higher patient satisfaction and quality of life for total knee replacement; comparable infection rates to conventional surgery for total hip replacement
increase in operative time for robotic-assisted procedures (91.5 vs. 87.1 minutes).When analyzed as a cohort, robotic and navigated techniques showed no significant difference in PJI (0.18% vs. 0.30%, p = 0.06) or SSSI rates (0.18% vs. 0.26%, p = 0.14) compared with conventional techniques."These
More news about: American Academy of Orthopaedic Surgeons
Mar 02, 2026, 01:01 ET E-bike injuries among youth surge over 300% as micromobility market expands
fractures (0.6 vs 0.2 fractures, p< 0.001) as compared to those involved in pedal-bike accidents.Patients in e-bike accidents were more likely to be older (12.6 vs. 10.3 years, p< 0.001) and more likely to have more socioeconomic advantage (based on ADI state quartile) (1.7 vs. 2.8 p< 0.001)
More news about: American Academy of Orthopaedic Surgeons
Mar 01, 2026, 19:00 ET Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
survival (PFS) compared with the investigator's choice regimen (14.0 months vs 8.7 months; hazard ratio [HR] = 0.54). In addition, the discontinuation rate due to treatment‑related adverse events was lower with pirtobrutinib (5.2% vs 21.1%), further supporting its efficacy and tolerability advantages in patients
More news about: Innovent Biologics
Feb 27, 2026, 18:28 ET Sunlight.com Survey: 1 in 5 Hiring Managers Admit They're Less Likely To Hire Overweight Candidates
bias varies across groups. Male hiring managers are nearly twice as likely as women to say a candidate's weight influences their first impression (34% vs. 18%). Managers ages 35 to 49 consistently report the highest bias across several measures, including being more likely to say they have given overweight
More news about: Sunlight
Feb 27, 2026, 15:51 ET FDA approves Novo Nordisk's Sogroya® as the first and only once-weekly, long-acting growth hormone for three additional pediatric indications
Sogroya® demonstrated non-inferiority compared to both daily growth hormone doses (0.035 mg/kg/day and 0.067 mg/kg/day) with a mean AHV of 11.0 cm/year vs 9.4 cm/year vs 11.1 cm year respectively; daily growth hormone dose of 0.035 mg/kg/day is less than the maximum approved dose (0.067 mg/kg/day) in the US.1In
More news about: Novo Nordisk
Feb 27, 2026, 13:33 ET Biglari Capital Calls for Immediate Resignation of Jack in the Box Chairman David Goebel, Who Was Overwhelmingly Rejected by Stockholders with "Skin in the Game"
following statement regarding the preliminary voting results from JACK's 2026 Annual Meeting of Stockholders. A Clear Divide: Accountability vs. Complacency Preliminary voting results from JACK's stockholder meeting reveal a stark and troubling divide. Active fund managers and retail
More news about: Biglari Capital Corp.
Feb 27, 2026, 11:30 ET GOFO en QLS bundelen krachten om e-commercelogistiek in Nederland te versterken
GOFO, opgericht in de Verenigde Staten in 2023, is een technologisch gedreven logistiek netwerk voor de last-mile dat handelaren en consumenten in de VS, Frankrijk, Nederland en Italië bedient. Gedreven door de merkfilosofie "Drive Efficiency, Deliver Trust", combineert GOFO geavanceerde technologie met
More news about: GOFO